Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective
About this item
Full title
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective
Author / Creator
Publisher
Springer
Journal title
Dermatology and Therapy, 2021, Vol.11 (6), p.2123
Language
English
Formats
Publication information
Publisher
Springer
Subjects
More information
Scope and Contents
Contents
Atopic dermatitis (AD), a predominantly type 2 inflammatory skin disease, affects approximately 2-5% of adults, with a high burden of disease. In moderate-to-severe AD, lesions can be extensive and pruritus intense with patients experiencing skin pain, sleep and mental health disturbances, and diminished quality of life (QoL). The objective of this...
Alternative Titles
Full title
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A683676023
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A683676023
Other Identifiers
ISSN
2193-8210
DOI
10.1007/s13555-021-00621-w
How to access this item
Log in as a Library member
